Olema Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (OLMA)
CUSIP: 68062P106
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 87,489,196
- Total 13F shares
- 57,896,539
- Share change
- +1,794,974
- Total reported value
- $626,445,097
- Put/Call ratio
- 59%
- Price per share
- $10.82
- Number of holders
- 127
- Value change
- +$18,080,243
- Number of buys
- 78
- Number of sells
- 60
Quarterly Holders Quick Answers
What is CUSIP 68062P106?
CUSIP 68062P106 identifies OLMA - Olema Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 68062P106:
Top shareholders of OLMA - Olema Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BVF INC/IL |
13F
|
Company |
10%
|
9,135,893
|
$103,418,309 | — | 31 Mar 2024 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
9%
|
7,903,600
|
$89,468,752 | — | 31 Mar 2024 | |
| Logos Global Management LP |
13F
|
Company |
5%
|
4,383,875
|
$49,625,465 | — | 31 Mar 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
3.7%
|
3,225,419
|
$36,511,743 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.7%
|
3,216,554
|
$36,411,391 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
3.6%
|
3,178,427
|
$35,979,794 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.8%
|
2,407,688
|
$27,255,028 | — | 31 Mar 2024 | |
| MPM BioImpact LLC |
13F
|
Company |
2.2%
|
1,953,690
|
$22,115,771 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2.2%
|
1,936,157
|
$21,917,298 | — | 31 Mar 2024 | |
| Vivo Capital, LLC |
13F
|
Company |
2.1%
|
1,873,704
|
$21,210,329 | — | 31 Mar 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.4%
|
1,221,662
|
$13,817,000 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.96%
|
839,345
|
$9,503,111 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.96%
|
835,613
|
$9,459,139 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.89%
|
780,660
|
$8,837,071 | — | 31 Mar 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.86%
|
750,279
|
$8,493,158 | — | 31 Mar 2024 | |
| Polar Capital Holdings Plc |
13F
|
Company |
0.86%
|
750,000
|
$8,490,000 | — | 31 Mar 2024 | |
| BRAIDWELL LP |
13F
|
Company |
0.81%
|
704,344
|
$7,973,174 | — | 31 Mar 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.75%
|
658,000
|
$7,448,560 | — | 31 Mar 2024 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.7%
|
610,649
|
$6,912,547 | — | 31 Mar 2024 | |
| Altium Capital Management LLC |
13F
|
Company |
0.69%
|
605,000
|
$6,848,600 | — | 31 Mar 2024 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
0.64%
|
559,035
|
$6,328,276 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.63%
|
547,803
|
$6,201,130 | — | 31 Mar 2024 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.59%
|
515,317
|
$5,833,388 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.57%
|
498,126
|
$5,638,787 | — | 31 Mar 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.53%
|
460,000
|
$5,207,200 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.5%
|
437,031
|
$4,947,191 | — | 31 Mar 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
0.4%
|
353,018
|
$3,996,164 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.4%
|
349,157
|
$3,952,458 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.37%
|
326,819
|
$3,699,591 | — | 31 Mar 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.36%
|
313,246
|
$3,545,945 | — | 31 Mar 2024 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.34%
|
294,719
|
$3,336,219 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.29%
|
249,982
|
$2,829,796 | — | 31 Mar 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.28%
|
249,030
|
$2,819,020 | — | 31 Mar 2024 | |
| HighVista Strategies LLC |
13F
|
Company |
0.28%
|
247,880
|
$2,806,002 | — | 31 Mar 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.23%
|
203,825
|
$2,307,299 | — | 31 Mar 2024 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.23%
|
200,000
|
$2,264,000 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.2%
|
173,161
|
$1,960,183 | — | 31 Mar 2024 | |
| Newtyn Management, LLC |
13F
|
Company |
0.17%
|
150,000
|
$1,698,000 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.17%
|
148,500
|
$1,681,020 | — | 31 Mar 2024 | |
| Exome Asset Management LLC |
13F
|
Company |
0.16%
|
143,400
|
$1,623,288 | — | 31 Mar 2024 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.16%
|
139,980
|
$1,584,574 | — | 31 Mar 2024 | |
| Monashee Investment Management LLC |
13F
|
Company |
0.15%
|
135,000
|
$1,528,200 | — | 31 Mar 2024 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.15%
|
129,587
|
$1,466,925 | — | 31 Mar 2024 | |
| Verition Fund Management LLC |
13F
|
Company |
0.14%
|
122,178
|
$1,383,055 | — | 31 Mar 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.12%
|
103,179
|
$1,167,000 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.12%
|
100,889
|
$1,142,063 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.11%
|
95,814
|
$1,084,614 | — | 31 Mar 2024 | |
| Atom Investors LP |
13F
|
Company |
0.11%
|
94,321
|
$1,067,714 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.1%
|
88,257
|
$999,069 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.1%
|
86,957
|
$984,353 | — | 31 Mar 2024 |
Institutional Holders of Olema Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (OLMA) as of Q2 2024
As of 30 Jun 2024,
Olema Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (OLMA) was held by
127 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
57,896,539 shares.
The largest 10 holders included
BVF INC/IL, Paradigm Biocapital Advisors LP, Deep Track Capital, LP, BlackRock Inc., Point72 Asset Management, L.P., Logos Global Management LP, VANGUARD GROUP INC, MPM BIOIMPACT LLC, STATE STREET CORP, and Vivo Capital, LLC.
This page lists
127
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
125
Q2 2024 holders
127
Holder diff
2
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.